Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dual therapy regimens for Helicobacter pylori eradication in treatment-naive adults in Israel
MOH_2019-02-27_006002Phase 4Completed
- Sponsor
- פרופ' ירון ניב
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole, amoxicillin, doxycycline and clarithromycin in Helicobacter pylori infection (3 arms), sponsored by פרופ' ירון ניב. Started Oct 2015; status: completed.
02
Drugs
esomeprazoleamoxicillindoxycyclineclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on MOH_2019-02-27_006002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-02-27_006002.